Stock screener

SPTX

Conviction 42HealthcareScan · Thu, Sep 24, 2026

Seaport Therapeutics, Inc. (SPTX) closed at $21.12 (-0.80%) on Sep 24, 2026. Price is below its 50-day. RSI(14) 42, -24.1% from its 52-week high, +6.5% year to date. Sector: Healthcare · Biotechnology.

SPTX$21.12-0.80%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 332.68K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Seaport Therapeutics, Inc.Biotechnologywww.seaporttx.com ↗
Price21.12
Change-0.80%
Gap-3.29%
Rel volume—
Avg volume270.71K
Avg $ vol6.03M
SMA 2023.15
SMA 5022.75
SMA 200—
Price vs 50-7.15%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 26.35
RSI (14)42
MACD hist-0.33
MACD cross—
Stoch %K / %D21 / 25
ADX (14)21
+DI / −DI18 / 20
RSI divergence—
MACD divergence—
ATR %9.08%
ADR %8.83%
52w high27.84
52w low15.25
From 52w high-24.14%
Above 52w low+38.49%
New 52w highNo
SqueezeOff
Bollinger width24.94%
%B0.15
Donchian pos13.87%
Donchian high28.38
Donchian low19.95
AVWAP (52w high)22.65
vs AVWAP high-6.77%
AVWAP (52w low)19.97
vs AVWAP low+5.74%
OBV trendDown
Chaikin MF (20)-0.47
Today vs 20d—
Avg vol (14d)332.68K
Avg vol (20d)270.71K
Avg $ vol (20d)6.03M
Market cap1.13B
RS Rating—
RS 3m (vs SPY)+4.60%
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank25.6
1 week-3.21%
1 month-14.94%
3 months+9.09%
6 months—
1 year—
YTD+6.45%
P/E—
P/B2.68
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current18.00
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target36.75
Target upside74.01%
Analyst ratingBuy
Institutional70.01%
Ent. value1.07B
Revenue—
Net income-62.6M
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out53.53M
Employees—
ListedFri, May 1, 2026
Free float18.43M
Float %34.4%
Short interest3.15M
Days to cover26.0d
Short volume93.7%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.78 vs −$0.71
Last surprise-150.7% miss
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank25.6 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance27.35
Support19.91
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Breaking out now
    Aug 5
    1 scan
  2. Broke out
    Aug 6 – Aug 10
    3 scans

Congress activity

Disclosed STOCK Act trades in SPTX

All disclosures →
No recent disclosed trades by Congress in SPTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SPTX

InsiderSideShares
PureTech Health plc
10% owner · Common Stock · 2026-05-04
Convert2.68M
PureTech LYT, Inc.
10% owner · Series A-2 Preferred Stock · 2026-05-04
Convert8.42M
PureTech Health plc
10% owner · Common Stock · 2026-05-04
Convert965.25K
PureTech LYT, Inc.
10% owner · Series B Preferred Stock · 2026-05-04
Convert3.03M
PureTech LYT, Inc.
10% owner · Series A-1 Preferred Stock · 2026-05-04
Convert40M
PureTech Health plc
10% owner · Series A-1 Preferred Stock · 2026-05-04
Convert40M
PureTech Health plc
10% owner · Series A-2 Preferred Stock · 2026-05-04
Convert8.42M
PureTech Health plc
10% owner · Series B Preferred Stock · 2026-05-04
Convert3.03M
PureTech LYT, Inc.
10% owner · Common Stock · 2026-05-04
Convert12.74M
PureTech Health plc
10% owner · Common Stock · 2026-05-04
Convert12.74M

SEC filings

EDGAR filings in SPTX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.